Establishment of a regression model of bone metabolism markers for the diagnosis of bone metastases in lung cancer
Abstract Background The aim of this study was to establish a regression equation model of serum bone metabolism markers. We analyzed the diagnostic value of bone metastases in lung cancer and provided laboratory evidence for the early clinical treatment of bone metastases in lung cancer. Methods A t...
Main Authors: | Zhongliang Zhu, Guangyu Yang, Zhenzhen Pang, Jiawei Liang, Weizhong Wang, Yonglie Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-021-02141-5 |
Similar Items
-
Progress of Biomarkers in Diagnosis of Bone Metastases of Lung Cancer
by: Chao MENG, et al.
Published: (2018-08-01) -
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”
by: Violetta Rosiek, et al.
Published: (2022-01-01) -
Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases
by: Jinxian He, et al.
Published: (2024-01-01) -
Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma
by: Theresa Stork, et al.
Published: (2021-04-01) -
Can clinical factors be determinants of bone metastases in non-small cell lung cancer ?
by: Ursavas Ahmet, et al.
Published: (2007-01-01)